Cannabis versus combination chemotherapy; n = 1 trial in Hodgkin’s lymphoma

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Guzman M, Duarte MJ, Blazquez C, Ravina J, Rosa MC et al (2006) A pilot clinical study of ∆9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer 95(2):197–203

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Ebel MD, Stellamanns J, Keinki C, Rudolph I, Huebner J (2017) Cancer patients and the internet: a survey among German cancer patients. J Canc Educ 32:503–508. https://doi.org/10.1007/s13187-015-0945-6

    Article  Google Scholar 

  3. 3.

    Dean LT, Moss SL, Mccarthy AM, Armstrong K (2017) Healthcare system distrust, physician trust, and patient discordance with adjuvant breast cancer treatment recommendations. Cancer Epidemiol Biomark Prev 26(12):1745–1752

    Article  Google Scholar 

  4. 4.

    Gauchat G (2012) Politicization of science in the public sphere: a study of public trust in the United States, 1974 to 2010. Am Sociol Rev 77(2):167–187. https://doi.org/10.1177/0003122412438225 http://asr.sagepub.com

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Louisa Jane Mc Sweeney.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mc Sweeney, L.J., Mc Eneaney, P. & O’Reilly, S. Cannabis versus combination chemotherapy; n = 1 trial in Hodgkin’s lymphoma. Ir J Med Sci 188, 1085–1086 (2019). https://doi.org/10.1007/s11845-018-1914-y

Download citation